In recent years, a photoreceptor system besides rods and cones has been discovered in the
mammalian retina, consisting of a sub-population of retinal ganglion cells that express the visual pigment,
melanopsin, and are intrinsically-photosensitive (ipRGCs). These ipRGCs comprise distinct subtypes. M1 cells
have the strongest melanopsin-immunoreactivity, the highest intrinsic photosensitivity, and the largest
saturated light response. M2 and M3 cells have weaker melanopsin-immunoreactivities, lower
photosensitivities, and much smaller saturated light responses. M1, M2 and M3 cells also differ in the location
of their dendritic arborizations in the inner plexiform layer of the retina. IpRGCs project predominantly to nonimage-
vision centers in the brain (e.g., most M1 cells), but they also project moderately to image-vision centers
(e.g., many M2 cells). Finally, there are supposedly M4 and M5 ipRGCs, but these are not detectable with
melanopsin-immunoreactivity, and have extremely low photosensitivities and small light responses. This
proposal deals only with M1-M3 ipRGCs, which may have differential functions with respect to both non-image
and image vision.
In order to fully understand the melanopsin system, it is important to know in detail the ipRGCs’ light
responses and their underlying mechanisms. We have recently carried out extensive physiological/biophysical
studies of M1 cells, and succeeded in resolving their single-photon response, estimating their melanopsin
density, and molecularly identifying some of their key phototransduction components. This grant will be a
continuation of these successful investigations. Aim 1 is to study M2 and M3 ipRGCs with respect to their
intensity-response relations, response kinetics, single-photon-responses, membrane melanopsin densities,
and their light-signaling thresholds, with the overall goal of comparing/contrasting M1, M2 and M3 cells. Aim 2
is to identify additional molecular components of phototransduction across M1, M2 and M3 cells, including the
signaling G protein. We shall also examine the gating mechanism for the TRPC channels underlying the light
response. Aim 3 is to begin to understand the termination mechanisms for the ipRGC’s light response,
including the significance of potential melanopsin phosphorylation, arrestin binding to melanopsin, and Gprotein
deactivation. Aim 4 is to study how M1, M2 and M3 ipRGCs adapt to steady light, and how this
adaptation in the receptor current translates into action-potential firing and therefore signaling to the brain. We
shall also investigate the involvement of Ca2+ in light adaptation.
In summary, ipRGCs are the only known non-rod/non-cone photoreceptors in the mammalian retina.
They are important for non-image vision and apparently also for subtle aspects of image vision. Therefore,
learning in detail how they function is of fundamental importance to vision in both health and disease.
Public Health Relevance Statement
The studies proposed in this application will enhance our understanding of phototransduction in
intrinsically-photosensitive retinal ganglion cells. Any new information derived from these studies will be highly
relevant to our knowledge about the normal and diseased states in human non-image and image vision.
Eye Disease and Disorders of Vision; Neurosciences
Sub Projects
No Sub Projects information available for 3R01EY014596-14S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R01EY014596-14S1
Patents
No Patents information available for 3R01EY014596-14S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R01EY014596-14S1
Clinical Studies
No Clinical Studies information available for 3R01EY014596-14S1
News and More
Related News Releases
No news release information available for 3R01EY014596-14S1
History
No Historical information available for 3R01EY014596-14S1
Similar Projects
No Similar Projects information available for 3R01EY014596-14S1